Phase 1 Unit, Rigshospitalet

🌟 Reflecting on 2024: Milestones in ProTarget 🌟 As the year concludes, we are happy to share highlights from ProTarget in 2024, which include the following major milestones: 🧬 Inclusion of 300 patients for biomarker-matched targeted treatment outside current EMA-label 🌍 Expansion of evidence for targeted treatments in collaboration with other DRUP-like Clinical Trials 🏆 Recognition of our innovative trial design at Danish Cancer Research Days ❤️ Sharing of patient stories that inspire us to continue our journey We are deeply grateful to our patients and their families for their participation, as well as our partners and supporters. With your trust and support, we are able to succeed on our mission. As we look forward to 2025, we will continue to push the boundaries of #precisiononcology by expanding our clinical and translational research activities striving to make precision medicine a reality for all cancer patients. Thank you for being part of this journey! 👇 Read the full story here Ulrik Niels Lassen Kristoffer Rohrberg Rikke Eefsen lise søndergaard Julie Gehl Annette Raskov Kodahl Lars Henrik Jensen Britt Elmedal Laursen Morten Ladekarl Tina Kringelbach Kristina Vile Jensen Tina Krogh Hansen Martin Højgaard Iben Spanggaard Rigshospitalet, Afdeling for Kræftbehandling, Herlev og Gentofte Hospital, Onkologisk Afdeling og Palliativ Enhed, SUH, Onkologisk Afdeling, OUH, SKA - Sammenslutningen af Kræftafdelinger, Dansk Selskab for Klinisk Onkologi (DSKO),  #SammenOmKræft #Rigshospitalet #ProTargetDenmark #DKD2024 #ESMO24 #DRUP #IMPRESSnorway FINPROVE trial PRIME-ROSE PCM4EU - Personalised Cancer Medicine for all EU citizens https://lnkd.in/dwrUJCa6

Meeting announcement: Clinical Cancer Genomics conference, March 20-21 2025, Amsterdam. We are pleased to announce that registration for this novel exciting meeting focused on cancer whole genome and transcriptome sequencing in a clinical setting, is now open. Please visit www.ccg2025.eu for more information, abstract submission or registration of your participation! An increasing number of European countries are adapting clinical cancer (gen)omics programs including whole genome and transcriptome sequencing (WGTS) to enable cancer precision medicine and support research and a learning health care system for improving future cancer care. This meeting will be the first of an annual recurring series and aims to bring together researchers and medical specialists involved in these programs or interested in genomics-based and data-driven cancer care and/or research. The current state-of-the-art of implementations in routine care, research highlights, clinical impact and future developments will be presented and discussed. National programs in Europe supporting translation of genomics approaches from the clinic to research and back will be central to this meeting. The first meeting will take place on Thursday March 20 and Friday 21, 2025 in Amsterdam, The Netherlands, and is initiated as part of the 10th anniversary of Hartwig Medical Foundation. The meeting will be organised together with Genomics England, DKFZ German Cancer Research Center MASTER/NCT, Genomic Medicine Sweden, Plan France Médecine Génomique 2025 , and Danish National Genome Center. #CCG2025, Edwin Cuppen, Matthew Brown, Stefan Fröhling, Frédérique Nowak, Richard Rosenquist Brandell, Bettina Lundgren

Decline and fall. This is a dramatic Sunday read.

Bliv komitémedlem! Er du forskningsaktiv læge? Vil du sikre videnskabsetikken i Danmark? Så skal du søge om en plads i vores videnskabsetiske medicinske komité. Se https://lnkd.in/gAJ-bqPr for mere info.